Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process.
Advancement in stem cell therapy, rising significance of nanotechnology and increased incidences of degenerative diseases are some of the factors driving demand in the global regenerative medicine market. In addition to this, use of nano materials in wound care, drug delivery and immunomodulation is also opening up new areas for the regenerative medicine market.
This report: Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 – 2020 provides a detailed analysis of the market and focuses on the major players, recent developments and key drivers of the global regenerative medicines market. It also assesses the key opportunities and essential trends in the market and outlines the factors that are present in the market and those which will be driving the growth of industry in the given forecast period.
The application of stem cells in emerging economies is contributing to the growth of the market. The developing nations are also adopting this technology to a great extent which is pushing the demand in the market at a rapid pace.
On the basis of the technology utilized, the market is duly segmented into small molecules and biologics, gene therapy and cell therapy. Among these, gene therapy is expected to record a CAGR of 28.6% till 2020, emerging as the fastest growing sector here. The key reason for the growth of this technology can be accredited to the use of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Based on applications, the market is classified into dermatology, cardiovascular, orthopaedic, dental and central nervous system (CNS). CNS is the fastest growing market among these, recording a CAGR of 30.8% during the forecast period 2014-2020. This is due to recent approvals for a regenerative product that is intended to cure multiple sclerosis and increasing number of clinical trials for neurodegenerative disorders.
The key players in the market include Shire pharmaceuticals, Advanced Cell Technology, Genzyme, Athersys Inc., Kinetic Concepts, Inc., NuVasive, Stem Cells, Inc., Cytori Therapeutics, Inc., Cytomedix, Inc. and Mesoblast Ltd. The key regions include North America, Europe, Asia-Pacific and LAMEA. Currently, North America is dominating the global market.
For further insights,
About Research on Global Markets
Research on Global Markets is a leading source for market research on various sectors globally, offering premium research content from worldwide publishers of market research reports. Our database hosts premium market research content developed by global publishers. It offers premium industry research reports, company profiles and country briefs. We have a dedicated team of research professionals who can facilitate, in an unbiased manner, the process of identifying appropriate market research reports that are targeted to fulfill all your information-related requirements.
For more details on the content of each report and ordering information please contact:
Email: [email protected]
US: +1 800 986 6819
UK: +44 203 514 2363
India: +91 22 4098 7600
Regenerative medicine market, regenerative medicine industry, regenerative medicine market size